RAAB MICHAEL 4
4 · ARDELYX, INC. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Ardelyx (ARDX) CEO Michael Raab Exercises Options, Sells Shares
What Happened
- Michael Raab, President & CEO and a director of Ardelyx (ARDX), exercised options to acquire 20,833 shares at $0.99 per share (cost ~$20,625) on March 16, 2026. On the same day he sold 41,666 shares in an open-market transaction at a weighted average price of $5.84 for total proceeds of $243,329. The filing also reports 20,833 shares disposed at $0.00 in connection with the derivative transaction (reported as such in the filing).
Key Details
- Transaction date: 2026-03-16.
- Option exercise: 20,833 shares acquired at $0.99 each (total ~$20,625).
- Derivative surrender/cancellation: 20,833 shares reported disposed at $0.00 (related to the exercise).
- Open-market sale: 41,666 shares sold at a weighted average price of $5.84 (prices ranged $5.79–$5.92) for $243,329 (footnote provides per-trade price breakdown on request).
- Plan: Sale executed pursuant to a 10b5-1 trading plan adopted by Raab on November 7, 2025.
- Shares owned after transaction: not specified in the provided filing summary.
- Filing timeliness: Report filed March 18, 2026 for trades on March 16, 2026 (appears timely).
- Other notes from filing: 1,128 ESPP shares acquired Feb 27, 2026; some shares are held in trusts (Michael G. Raab Living Trust and trusts for his children). The reported option vests monthly over 48 installments beginning Jan 6, 2022.
Context
- This was an exercise of options combined with an open-market sale executed under a pre-arranged 10b5-1 plan. The presence of a 10b5-1 plan indicates the sales were pre-scheduled and are often routine; it does not by itself indicate a change in insider sentiment. The zero-dollar disposition reported for 20,833 shares reflects shares surrendered/used in connection with the option exercise as reported in the Form 4 (not a market sale).
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
RAAB MICHAEL
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-16$0.99/sh+20,833$20,625→ 1,856,986 total - Sale
Common Stock
[F1][F2][F3]2026-03-16$5.84/sh−41,666$243,329→ 1,816,448 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F6]2026-03-16−20,833→ 374,168 totalExercise: $0.99Exp: 2032-01-06→ Common Stock (20,833 underlying)
Holdings
- 24,364(indirect: By Trust)
Common Stock
[F4] - 1,000(indirect: By Trust)
Common Stock
[F5]
Footnotes (6)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.
- [F2]Transaction was executed in multiple trades in prices ranging from $5.79 to $5.92, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,128 shares acquired under the Issuer's employee stock purchase plan on February 27, 2026.
- [F4]The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
- [F5]The shares are owned directly by trusts for the benefit of the Reporting Person's children.
- [F6]The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Michael Raab|2026-03-18